Lazuriton Nano Biotechnology (U.S.A.) Inc.: cashflow_operating
| Value | {"amount": 150, "concept": "us-gaap:NetCashProvidedByUsedInOperatingActivities", "currency": "USD"} |
|---|---|
| Period | 2019-01-01 – 2019-12-31 |
| Status | current |
| Entity | Lazuriton Nano Biotechnology (U.S.A.) Inc. |
Provenance
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
Retrieved: 2026-08-19T17:07:30.346437+02:00
Raw response sha256:
Also addressable by official identifiers:
Cite as: FACTANKER, https://factanker.com/fact/a475ec99-adf7-449f-b05f-9b83d7cd032e
Source: SEC EDGAR CompanyFacts (US-PD-17USC105)
Reference:
0001640334-21-001627Retrieved: 2026-08-19T17:07:30.346437+02:00
Raw response sha256:
f7bde1a401b286c74a2fd824ee1df541…Also addressable by official identifiers:
https://factanker.com/fact/sec/cik-0001666178/cashflow-operating/2019-12-31 (CIK, metric, reporting date)Cite as: FACTANKER, https://factanker.com/fact/a475ec99-adf7-449f-b05f-9b83d7cd032e
History
- no predecessors — first report